Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last CNY37.30 CNY
Change Today +1.20 / 3.32%
Volume 13.0M
002219 On Other Exchanges
As of 3:00 AM 04/30/15 All times are local (Market data is delayed by at least 15 minutes).

hengkang medical group co -a (002219) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/14/15 - CNY39.99
52 Week Low
05/16/14 - CNY16.90
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for HENGKANG MEDICAL GROUP CO -A (002219)

Related News

No related news articles were found.

hengkang medical group co -a (002219) Related Businessweek News

No Related Businessweek News Found

hengkang medical group co -a (002219) Details

Hengkang medical Group Co., Ltd. is engaged in the research, development, manufacture, and sale of traditional Chinese medicines in China and internationally. Its products include analgesic and haemostatic drugs, including Duyiwei Capsules; drugs for replenishing Qi, nourishing blood, and tranquillization, such as Shenqi Wuweizi tablets; cardiovascular drugs comprising Maiping tablets; and drugs for urinary and reproductive systems, including Qianlie Antong tablets. The company offers its products in various forms, including tablet, syrup, granular, pulvis, vinum, hard capsule, soft capsule, oral liquid, mixture, pill, dripping pill, and others. The company was formerly known as Gansu Duyiwei Biological Pharmaceutical Co., Ltd. and changed its name to Hengkang medical Group Co., Ltd. in January 2014. Hengkang medical Group Co., Ltd. is based in Chengdu, China.

hengkang medical group co -a (002219) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

hengkang medical group co -a (002219) Key Developments

Hengkang medical To Sell Two Sichuan Based Units

Hengkang medical Group Co., LTD. (SZSE:002219) is planning to sell two Sichuan Province-based health care service units for a CNY 75 million before August 1, 2015. Hengkang medical intends to use proceeds from the sale to replenish working capital.

Hengkang medical Group Co., LTD., Special/Extraordinary Shareholders Meeting, Mar 04, 2015

Hengkang medical Group Co., LTD., Special/Extraordinary Shareholders Meeting, Mar 04, 2015., at 15:30 China Standard Time. Agenda: To consider investment in setup of wholly-owned subsidiary.

Hengkang medical Group Co., LTD. to Report Fiscal Year 2014 Results on Apr 29, 2015

Hengkang medical Group Co., LTD. announced that they will report fiscal year 2014 results on Apr 29, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002219:CH CNY37.30 CNY +1.20

002219 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002219.
View Industry Companies

Industry Analysis


Industry Average

Valuation 002219 Industry Range
Price/Earnings 89.0x
Price/Sales 32.8x
Price/Book 23.6x
Price/Cash Flow 89.0x
TEV/Sales 31.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HENGKANG MEDICAL GROUP CO -A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at